SPERO THERAPEUTICS INC. - COMMON STOCK

0.8677

24-January-25 15:45:00

15 minutes delayed

Stocks

-0.0031

-0.36%

Today's range

0.8522 - 0.8800

ISIN

N/A

Source

NASDAQ

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full-Year 2020 Financial Results on Thursday, March 11, 2021

03 Mar 2021 07:30:00 By Nasdaq GlobeNewswire
Spero Therapeutics to Present at Investor Conferences in March

25 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Spero Therapeutics Provides Update on SPR720 Phase 2a Clinical Trial

05 Feb 2021 07:00:00 By Nasdaq GlobeNewswire
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 Jan 2021 16:17:29 By Nasdaq GlobeNewswire
Spero Therapeutics Announces Issuance of Allowance for a U.S. Patent Covering Lead Candidate Tebipenem HBr

21 Jan 2021 07:00:01 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.